Troglitazone
Alternative Names: CI 991; CS 045; GR 92132; GR 92132X; Noscal; Prelay; Rezulin; RomozinLatest Information Update: 05 Nov 2023
At a glance
- Originator Daiichi Sankyo Company
- Developer Daiichi Sankyo Company; Pfizer
- Class Antihyperglycaemics; Small molecules; Thiazolidinediones
- Mechanism of Action Apoptosis stimulants; Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Market Withdrawal Type 2 diabetes mellitus
- Discontinued Cancer; Female infertility; Polycystic ovary syndrome